Rob Stein

Rob Stein appears in the following:

Pfzier and Moderna seek authorization of omicron booster for kids ages 5-11

Monday, September 26, 2022

Pfzier-BioNTech and Moderna are asking the Food and Drug Administration to authorize the new omicron boosters for young children.

Comment

Flu is expected to flare up in U.S. this winter, raising fears of a 'twindemic'

Friday, September 23, 2022

After virtually disappearing for the last two years, there are troubling clues that the flu could come roaring back this year, to cause trouble alongside COVID.

Comment

How Biden's declaring the pandemic 'over' complicates efforts to fight COVID

Tuesday, September 20, 2022

Biden's comments — made as officials try to convince Americans to get a new booster shot and the White House seeks $22 billion in new COVID funding — were "unfortunate," several epidemiologists said.

Comment

Biden's remarks that the pandemic is over hurts efforts to save lives, experts say

Monday, September 19, 2022

President Biden says the pandemic "is over," but public health experts, epidemiologists, infectious disease researchers and others strongly disagree, saying his remarks endanger efforts to save lives.

Comment

Omicron booster finds few takers

Saturday, September 17, 2022

How has the rollout of the new COVID-19 vaccine boosters gone so far? Shots are plentiful, waits are short, but demand is uncertain.

Comment

Making sense of COVID-19's risk now

Friday, September 16, 2022

It's a strange moment in the pandemic. For most vaccinated people, the risk of severe illness has gone way down. But hundreds are dying of COVID-19 every day. So how dangerous is the virus now?

Comment

Scientists debate how lethal COVID is. Some say it's now less risky than flu

Friday, September 16, 2022

They argue the threat posed by COVID has lessened because of preexisting immunity and access to treatment. Plus, some deaths may be incorrectly blamed on COVID. Others caution it's too soon to tell.

Comment

The new COVID booster could be the last you'll need for a year, federal officials say

Tuesday, September 06, 2022

The COVID-19 vaccine strategy may be shifting toward Americans getting yearly vaccinations, like many do with annual flu shots.

Comment

New COVID-19 boosters to be available for those 12 and up

Saturday, September 03, 2022

New COVID-19 vaccine boosters designed to combat recent subvariants of the coronavirus are being made available to people over 12 years old. We have some guidance on who should get one and when.

Comment

CDC recommends new booster shots to fight omicron

Thursday, September 01, 2022

CDC Director Rochelle Walensky has signed off on updated versions of the Moderna and Pfizer-BioNTech vaccines that target the original virus and the omicron subvariants.

Comment

FDA authorizes new boosters targeting omicron

Thursday, September 01, 2022

The FDA is authorizing new booster shots to protect people against another surge of omicron infections this fall and winter.

Comment

FDA authorizes omicron boosters

Wednesday, August 31, 2022

The Food and Drug Administration authorized the first updated COVID-19 vaccines since the pandemic began — boosters targeted at the omicron variant.

Comment

FDA authorizes first revamp of COVID vaccines to target omicron

Wednesday, August 31, 2022

The new shots from Moderna and Pfizer-BioNTech target both the original strain of the coronavirus and the omicron BA.4/BA.5 subvariants that most people are catching now.

Comment

FDA expected to authorize new omicron-specific COVID boosters this week

Tuesday, August 30, 2022

The Food and Drug Administration is planning to authorize a new generation of COVID-19 boosters this week that for the first time will target the omicron variant.

Comment

What's behind the FDA's controversial strategy for evaluating new COVID boosters

Thursday, August 18, 2022

Some scientists are alarmed that the agency plans to evaluate the next generation of boosters by reviewing mouse studies alone. Others say there's no time to waste waiting for human trials.

Comment

The FDA is not expanding eligibility for 2nd COVID boosters

Thursday, August 04, 2022

The Food and Drug Administration's decision against allowing more people to get second boosters has left many younger adults in limbo and angry.

Comment

Summer boosters for people under 50 shelved in favor of updated boosters in the fall

Thursday, July 28, 2022

The Biden administration is scrapping plans to offer COVID boosters for people under 50 this summer. Instead officials will push for an earlier release of the next generation boosters in the fall.

Comment

Officials boost access to a drug that can protect the immunocompromised from COVID-19

Thursday, July 28, 2022

Evusheld, a course of injected antibodies, helps protect people with weak immune systems for up to six months. The government is making it available through pharmacies and individual providers.

Comment

Reformulated COVID vaccine boosters may be available earlier than expected

Tuesday, July 26, 2022

The Biden administration may scrap plans to expand eligibility for second boosters to younger adults. Instead, it's trying to speed up the next generation of boosters targeting the omicron variant.

Comment

New COVID strain is highly contagious but symptoms mild for the vaccinated

Saturday, July 23, 2022

President Biden's COVID infection underscores a new surge of the pandemic, with another highly contagious virus strain and a federal scramble to provide more boosters to try to protect people.

Comment